A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Clinical trial NCT03464097 · TERMINATED
Trial details
- NCT number
- NCT03464097
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-27
- Primary completion
- 2024-10-03
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.